Excellence in Research and Innovation for Humanity

ICCIR 2019 : 21st International Conference on Cancer Immunotherapy and Radiotherapy

Kyoto, Japan
April 27 - 28, 2019

ICCIR 2019 : 21st International Conference on Cancer Immunotherapy and Radiotherapy


Medical and Health Sciences
Japan
Kyoto
Abstracts/Full-Text Paper Submission Deadline   2018-06-27 00:00:00
Notification of Acceptance   2018-10-30 00:00:00
Final Paper (Camera Ready) Submission &
Early Bird Registration Deadline
  2019-03-27 00:00:00
Conference Dates   Apr 27-28, 2019
The ICCIR 2019: 21st International Conference on Cancer Immunotherapy and Radiotherapy aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Cancer Immunotherapy and Radiotherapy. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Cancer Immunotherapy and Radiotherapy.
Biomarkers for breast cancer
Biomarkers for lung cancer
Biomarkers for prostate cancer
Biomarkers for blood cancer
Biomarkers for colorectal cancer
Biomarkers for ovarian cancer
Targeted therapies
Rationale for immunotherapy
Combining radiotherapy
Standard therapies
Androgen manipulation
T-cell modulation
Human cancer stemcells immune biological properties
Novel phosphatidyl service targeting immunotherapy cancer treatment
Targeting myeloma microenvironment with immunotherapy
Bite antibodies application in solid tumours
International Science Index
Cancer Immunotherapy, Radiotherapy
cancer biomarkers, cancer metabolomics and biomarkers, immunotherapy, targeted therapies, therapies, manipulation, radiotherapy
International Medical and Health Sciences Committee